Genetic screening for HCM a “highly cost-effective” option Clinical study 14 January 2013 Pages: 1 - 1
Adding zoledronic acid to endocrine therapy highly cost effective Clinical study 14 January 2013 Pages: 2 - 2
Benchmark cost effectiveness for “off label” drug-eluting stents Clinical study 14 January 2013 Pages: 2 - 2
Barriers to opioid analgesics for cancer pain evident in East Europe Clinical study 14 January 2013 Pages: 3 - 3
Higher volume hospitals reduce mortality in common conditions Clinical study 14 January 2013 Pages: 3 - 3
No support for preventive primary care outreach for the elderly Clinical study 14 January 2013 Pages: 3 - 3
Insurance worries cause delays in seeking treatment for AMI Clinical study 14 January 2013 Pages: 4 - 4
Rosuvastatin best cost option for dyslipidaemia in Mexico Clinical study 14 January 2013 Pages: 5 - 5
School-based asthma screening not likely to be worth it in the US Clinical study 14 January 2013 Pages: 5 - 5
Universal prenatal screening for SMA doesn't stack up in the US Clinical study 14 January 2013 Pages: 7 - 7
Current physician cost-profiling methods misleading in the US Clinical study 14 January 2013 Pages: 8 - 8
Endovascular repair not best option for abdominal aortic aneurysm Clinical study 14 January 2013 Pages: 8 - 8
Postpartum contraception for new Latina immigrants to the US saves costs Clinical study 14 January 2013 Pages: 8 - 8
Mometasone/formoterol provides clinically meaningful improvement in QOL Clinical study 14 January 2013 Pages: 10 - 10
Strong growth predicted for ovarian cancer & IBS drug markets News item 14 January 2013 Pages: 11 - 11